fig6
![Promising future: a review of clinical applications of biopolymers in renal cell carcinoma](https://image.oaes.cc/b4c12267-660c-48fc-8ab1-639f47b0e0d7/jcmt4012.fig.6.jpg)
Figure 6. Illustration depicting the synthesis process of drug-incorporated liposomes[8]. DOPC: 1,2-dioleoyl-sn-glycero-3-phosphocholine; TTP: tumor targeting peptide; DSPE-PEG2000-Ome: 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt).